1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Biotechnology
Salarius Pharmaceuticals, Inc.

Salarius Pharmaceuticals, Inc.

SLRX
Salarius Pharmaceuticals, Inc.US flagNASDAQ Capital Market
0.84
USD
+0.19
- -
4.92MMarket Cap

Income Statement (USD)

APIChat
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
Sales/Revenue/Turnover
- -
- -
1
1
1
3
- -
- -
- -
- -
- -
+ Sales & Services Revenue
- -
- -
1
1
1
3
- -
- -
- -
- -
- -
- Cost of Revenue
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
+ Cost of Goods & Services
- -
- -
1
1
- -
- -
- -
- -
- -
- -
- -
Gross Profit
- -
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
+ Other Operating Income
- -
- -
- -
- -
- -
-3
- -
- -
- -
- -
- -
- Operating Expenses
- -
29
40
35
22
12
8
13
23
13
6
+ Selling, General & Admin
- -
16
20
19
11
8
6
6
7
6
5
+ Research & Development
- -
13
20
17
12
4
7
9
16
7
1
+ Other Operating Expense
- -
- -
- -
- -
- -
- -
-5
-2
- -
- -
- -
Operating Income (Loss)
- -
-29
-40
-35
-22
-8
-8
-13
-23
-13
-6
- Non-Operating (Income) Loss
- -
- -
- -
- -
- -
-1
- -
- -
9
- -
- -
+ Interest Expense, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Interest Income
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Non-Op (Income) Loss
- -
- -
- -
- -
- -
-1
- -
- -
9
- -
- -
Pretax Income
- -
-29
-39
-34
-22
-7
-7
-13
-32
-13
-6
- Income Tax Expense (Benefit)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- (Income) Loss from Affiliates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) from Cont Ops
- -
-29
-39
-34
-22
-7
-7
-13
-32
-13
-6
- Net Extraordinary Losses (Gains)
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Discontinued Operations
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Extraord. & Accounting Changes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Income (Loss) Incl. MI
- -
-29
-39
-34
-22
-7
-7
-13
-32
-13
-6
- Minority Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income, GAAP
- -
-29
-39
-34
-22
-7
-7
-13
-32
-13
-6
- Preferred Dividends
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- Other Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Income Avail to Common, GAAP
- -
-29
-39
-34
-22
-7
-7
-13
-32
-13
-6
EBIT
- -
-29
-40
-35
-22
-8
-8
-13
-23
-13
-6
EBITDA
- -
-29
-40
-34
-22
-8
-8
-13
-23
-13
-6
EBITDA Margin (%)
- -
- -
-3,919.11
-2,699.18
-2,606.49
-234.8
- -
- -
- -
- -
- -
EBITA
- -
-29
-40
-35
-22
-8
-8
-13
-23
-13
-6
Gross Margin (%)
- -
- -
34.42
60.26
48.61
100
100
- -
- -
- -
- -
Operating Margin (%)
- -
- -
-3,946.54
-2,724.65
-2,633.71
-238.47
- -
- -
- -
- -
- -
Profit Margin (%)
- -
- -
-3,907.65
-2,701.74
-2,615.57
-200.18
- -
- -
- -
- -
- -
Sales per Employee
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Dividend per Share
- -
- -
- -
- -
- -
1,068.75
- -
- -
- -
- -
- -
Depreciation Expense
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Basic EPS, GAAP
- -
-1,714,213.53
-2,194,062.39
-1,812,298
-1,096,110.85
-55,490.1
-11,122.93
-11,112.48
-21,429.12
-5,532.73
-1,043.18
Basic EPS from Cont Ops
- -
-1,714,213.53
-2,194,062.39
-1,812,298
-1,096,110.85
-55,490.1
-11,122.93
-11,112.48
-21,429.12
-5,532.73
-1,043.18
Diluted Weighted Avg Shares
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Diluted EPS, GAAP
- -
-1,714,213.53
-2,194,062.39
-1,812,298
-1,096,110.85
-55,490.1
-11,122.93
-11,112.48
-21,429.12
-5,532.73
-1,043.18
Diluted EPS from Cont Ops
- -
-1,714,213.53
-2,194,062.39
-1,812,298
-1,096,110.85
-55,490.1
-11,122.93
-11,112.48
-21,429.12
-5,532.73
-1,043.18

Balance Sheet (USD)

APIChat
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
Total Current Assets
34
92
62
35
10
5
16
30
15
7
3
+ Cash, Cash Equivalents & STI
34
91
61
33
10
4
11
29
12
6
2
+ Cash & Cash Equivalents
34
67
22
19
10
4
11
29
12
6
2
+ ST Investments
- -
25
39
14
- -
- -
- -
- -
- -
- -
- -
+ Accounts & Notes Receiv
- -
- -
- -
- -
- -
- -
4
- -
2
- -
- -
+ Accounts Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Notes Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Loans Receivable, Net
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Receivable, Net
- -
- -
- -
- -
- -
- -
4
- -
2
- -
- -
+ Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Raw Materials
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Work In Process
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Finished Goods
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Inventory Adjustments
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Inventory
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Assets
- -
1
1
1
- -
1
1
1
1
1
1
+ Misc ST Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Prepaid Expenses
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Assets Held-for-Sale
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ ST Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Assets
1
3
1
- -
- -
9
9
11
- -
- -
- -
+ Property, Plant & Equip, Net
- -
- -
1
- -
- -
- -
- -
- -
- -
- -
- -
+ Property, Plant & Equip
- -
- -
1
1
1
- -
- -
- -
- -
- -
- -
- Accumulated Depreciation
- -
- -
- -
1
1
- -
- -
- -
- -
- -
- -
+ LT Investments & Receivables
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Investments
- -
2
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Receivables
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Assets
1
- -
- -
- -
- -
9
9
11
- -
- -
- -
+ Total Intangible Assets
- -
- -
- -
- -
- -
9
9
9
- -
- -
- -
+ Goodwill
- -
- -
- -
- -
- -
9
9
9
- -
- -
- -
+ Other Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Deferred Tax Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Derivative & Hedging Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Assets
1
- -
- -
- -
- -
- -
- -
2
- -
- -
- -
Total Assets
36
95
63
35
10
14
25
41
15
7
3
+ Payables & Accruals
1
3
4
6
1
2
2
2
4
1
1
+ Accounts Payable
1
1
1
2
- -
2
2
2
3
1
1
+ Accrued Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Interest & Dividends Payable
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Payables & Accruals
- -
2
3
4
1
- -
- -
1
1
- -
- -
+ ST Debt
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
+ ST Borrowings
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
+ ST Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other ST Liabilities
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
1
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc ST Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Current Liabilities
1
3
4
6
1
3
3
2
4
1
2
+ LT Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Borrowings
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ LT Finance Leases
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other LT Liabilities
41
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Accrued Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Pension Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Revenue
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Deferred Tax Liabilities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Derivatives & Hedging
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Misc LT Liabilities
41
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Noncurrent Liabilities
41
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Liabilities
42
3
4
6
1
3
3
2
4
1
2
+ Preferred Equity and Hybrid Capital
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Share Capital & APIC
1
129
136
140
142
23
42
71
74
82
83
+ Common Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Additional Paid in Capital
1
129
136
140
142
23
42
71
74
82
83
- Treasury Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Retained Earnings
-8
-37
-77
-111
-133
-12
-19
-32
-64
-76
-82
+ Other Equity
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Equity Before Minority Interest
-7
92
59
29
9
11
22
39
10
5
2
+ Minority/Non Controlling Interest
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Total Equity
-7
92
59
29
9
11
22
39
10
5
2
Total Liabilities & Equity
36
95
63
35
10
14
25
41
15
7
3
Shares Outstanding
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Number of Employees
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Capital Leases - Total
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Debt
-34
-67
-22
-19
-10
-3
-11
-29
-12
-6
-2
Net Debt to Equity
517.78
-72.33
-37.79
-65.92
-105.89
-30.59
-48.02
-75.44
-116.58
-106.11
-146.37
Tangible Common Equity Ratio
-18.36
96.97
93.83
83.18
89.35
34.1
82.74
93.4
70.88
80.27
50.01
Current Ratio
32.07
32.4
16.06
5.91
9.32
1.42
5.7
14.29
3.4
5.02
1.98
Cash Conversion Cycle
- -
- -
-210.63
-882.16
-2,038.94
- -
- -
- -
- -
- -
- -

Cash Flow Statement (USD)

APIChat
2014 Y
2015 Y
2016 Y
2017 Y
2018 Y
2019 Y
2020 Y
2021 Y
2022 Y
2023 Y
2024 Y
+ Net Income
- -
-29
-39
-34
-22
-7
-7
-13
-32
-13
-6
+ Depreciation & Amortization
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Non-Cash Items
- -
7
7
4
2
-1
- -
1
12
1
- -
+ Stock-Based Compensation
- -
7
7
4
2
1
- -
1
1
1
- -
+ Deferred Income Taxes
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Asset Impairment Charge
- -
- -
- -
- -
- -
- -
- -
- -
9
- -
- -
+ Other Non-Cash Adj
- -
- -
- -
- -
- -
-1
- -
- -
2
- -
- -
+ Chg in Non-Cash Work Cap
- -
2
1
2
-4
-4
-3
2
2
-1
1
+ (Inc) Dec in Accts Receiv
- -
- -
- -
- -
- -
- -
-4
2
- -
1
- -
+ (Inc) Dec in Inventories
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ (Inc) Dec in Prepaid Assets
- -
-1
- -
- -
1
- -
1
- -
- -
1
- -
+ Inc (Dec) in Accts Payable
- -
2
1
2
-5
-1
- -
- -
2
-3
- -
+ Inc (Dec) in Other
- -
- -
- -
- -
- -
-3
-1
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Operating Activities
- -
-21
-32
-28
-24
-12
-10
-10
-18
-13
-5
+ Change in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp in Fixed & Intang
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Fixed Prod Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Disp of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Fixed & Intang
- -
- -
-1
- -
- -
- -
- -
- -
-2
- -
- -
+ Acq of Fixed Prod Assets
- -
- -
-1
- -
- -
- -
- -
- -
- -
- -
- -
+ Acq of Intangible Assets
- -
- -
- -
- -
- -
- -
- -
- -
-2
- -
- -
+ Cash (Repurchase) of Equity
- -
80
- -
- -
- -
4
15
27
2
7
2
+ Increase in Capital Stock
- -
80
- -
- -
- -
4
15
27
2
7
2
+ Decrease in Capital Stock
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Change in LT Investment
- -
-27
-12
25
14
- -
- -
- -
- -
- -
- -
+ Dec in LT Investment
- -
12
27
58
16
- -
- -
- -
- -
- -
- -
+ Inc in LT Investment
- -
-39
-39
-33
-2
- -
- -
- -
- -
- -
- -
+ Net Cash From Acq & Div
- -
- -
- -
- -
- -
6
- -
- -
- -
- -
- -
+ Cash from Divestitures
- -
- -
- -
- -
- -
6
- -
- -
- -
- -
- -
+ Cash for Acq of Subs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Cash for JVs
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Other Investing Activities
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Investing Activities
- -
-27
-12
24
14
6
- -
- -
-2
- -
- -
+ Dividends Paid
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Net Cash From Debt
- -
- -
- -
- -
- -
-1
-2
-1
- -
- -
- -
+ Cash From Debt
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
+ Repayments of Debt
- -
- -
- -
- -
- -
-1
-2
-1
- -
- -
- -
+ Other Financing Activities
- -
- -
- -
- -
- -
- -
5
2
- -
- -
- -
+ Net Cash From Disc Ops
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Cash from Financing Activities
- -
81
- -
- -
- -
4
18
28
2
7
1
Effect of Foreign Exchange Rates
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Net Changes in Cash
- -
33
-44
-3
-9
-2
7
18
-17
-6
-3
EBITDA
- -
-29
-40
-34
-22
-8
-8
-13
-23
-13
-6
EBITDA Margin (%)
- -
- -
-3,919.11
-2,699.18
-2,606.49
-234.8
- -
- -
- -
- -
- -
Free Cash Flow
- -
-21
-33
-28
-24
-12
-10
-10
-19
-13
-5
Net Cash Paid for Acquisitions
- -
- -
- -
- -
- -
-6
- -
- -
- -
- -
- -
Free Cash Flow to Firm
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
Free Cash Flow to Equity
- -
-21
-33
-28
-24
-12
-12
-11
-18
-13
-5
Free Cash Flow per Basic Share
- -
-1,235,984.41
-1,811,749.5
-1,465,036.63
-1,179,933
-92,640.77
-15,603.57
-8,877.46
-12,945.98
-5,666.58
-846.65
Price/Free Cash Flow
- -
-0.78
-0.23
-0.18
-0.02
-0.12
-0.18
-0.17
-0.02
-0.01
-0.03
Cash Flow to Net Income
- -
0.71
0.81
0.81
1.08
1.67
1.4
0.8
0.56
1.02
0.81
Capital Expenditures
- -
- -
-1
- -
- -
- -
- -
- -
-2
- -
- -